Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Scarab Genomics

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 27 April 1984:
Vol. 224. no. 4647, pp. 417 - 419
DOI: 10.1126/science.6200934

Articles

Science, Vol 224, Issue 4647, 417-419
Copyright © 1984 by American Association for the Advancement of Science


articles

Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells

GT Merlino, YH Xu, S Ishii, AJ Clark, K Semba, K Toyoshima, T Yamamoto, and I Pastan

The sequence of the human epidermal growth factor (EGF) receptor shows great homology with the avian erythroblastosis virus v-erb B oncogene, raising the possibility that the receptor gene is identical to the c-erb B protooncogene. Human A431 epidermoid carcinoma cells, which have an unusually high number of EGF receptors, were examined to determine whether elevated EGF receptor levels correlate with gene amplification. Southern blots of genomic DNA's from A431 and other human cell lines were probed with either a v-erb B gene fragment or a human EGF receptor complementary DNA clone (pE7), previously isolated from an A431 complementary DNA library. When either probe was used to analyze Eco RI- or Hind III-generated DNA fragments, EGF receptor DNA sequences were amplified about 30-fold in A431. Differences in the banding pattern of A431 DNA fragments relative to normal fibroblast DNA indicate the occurrence of a rearrangement in the region of the receptor gene. Furthermore, A431 cells contain a characteristic, prominent 2.9-kilobase RNA. These results are consistent with the hypothesis that, in A431 cells, gene amplification, possibly associated with a translocation event, may result in the overproduction of EGF receptor protein or the appearance of the transformed phenotype (or both).


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Insulin-like Growth Factor-1 Receptor and ErbB Kinase Inhibitor Combinations Block Proliferation and Induce Apoptosis through Cyclin D1 Reduction and Bax Activation.
J. L. Wilsbacher, Q. Zhang, L. A. Tucker, R. D. Hubbard, G. S. Sheppard, N. Y. Bamaung, S. D. Fidanze, G. T. Wang, X. Hu, S. K. Davidsen, et al. (2008)
J. Biol. Chem. 283, 23721-23730
   Abstract »    Full Text »    PDF »
Genome-wide DNA copy number predictors of lapatinib sensitivity in tumor-derived cell lines.
J. Greshock, J. Cheng, D. Rusnak, A. M. Martin, R. Wooster, T. Gilmer, K. Lee, B. L. Weber, and T. Zaks (2008)
Mol. Cancer Ther. 7, 935-943
   Abstract »    Full Text »    PDF »
Heparin-binding EGF-like growth factor mediates oxyhemoglobin-induced suppression of voltage-dependent potassium channels in rabbit cerebral artery myocytes.
M. Koide, P. L. Penar, B. I. Tranmer, and G. C. Wellman (2007)
Am J Physiol Heart Circ Physiol 293, H1750-H1759
   Abstract »    Full Text »    PDF »
Epidermal Growth Factor Receptor (EGFR) Antibody Down-regulates Mutant Receptors and Inhibits Tumors Expressing EGFR Mutations.
M. Perez-Torres, M. Guix, A. Gonzalez, and C. L. Arteaga (2006)
J. Biol. Chem. 281, 40183-40192
   Abstract »    Full Text »    PDF »
Monitoring Tumor Glucose Utilization by Positron Emission Tomography for the Prediction of Treatment Response to Epidermal Growth Factor Receptor Kinase Inhibitors..
H. Su, C. Bodenstein, R. A. Dumont, Y. Seimbille, S. Dubinett, M. E. Phelps, H. Herschman, J. Czernin, and W. Weber (2006)
Clin. Cancer Res. 12, 5659-5667
   Abstract »    Full Text »    PDF »
Increased Epidermal Growth Factor Receptor Gene Copy Number Is Associated With Poor Prognosis in Head and Neck Squamous Cell Carcinomas.
C. H. Chung, K. Ely, L. McGavran, M. Varella-Garcia, J. Parker, N. Parker, C. Jarrett, J. Carter, B. A. Murphy, J. Netterville, et al. (2006)
J. Clin. Oncol. 24, 4170-4176
   Abstract »    Full Text »    PDF »
Predictive Factors for Interstitial Lung Disease, Antitumor Response, and Survival in Non-Small-Cell Lung Cancer Patients Treated With Gefitinib.
M. Ando, I. Okamoto, N. Yamamoto, K. Takeda, K. Tamura, T. Seto, Y. Ariyoshi, and M. Fukuoka (2006)
J. Clin. Oncol. 24, 2549-2556
   Abstract »    Full Text »    PDF »
Src Homology 2 Domain-based High Throughput Assays for Profiling Downstream Molecules in Receptor Tyrosine Kinase Pathways.
T. Yaoi, S. Chamnongpol, X. Jiang, and X. Li (2006)
Mol. Cell. Proteomics 5, 959-968
   Abstract »    Full Text »    PDF »
Epithelial versus Mesenchymal Phenotype Determines In vitro Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients.
R. L. Yauch, T. Januario, D. A. Eberhard, G. Cavet, W. Zhu, L. Fu, T. Q. Pham, R. Soriano, J. Stinson, S. Seshagiri, et al. (2005)
Clin. Cancer Res. 11, 8686-8698
   Abstract »    Full Text »    PDF »
Proliferation of Human Neuroblastomas Mediated by the Epidermal Growth Factor Receptor.
R. Ho, J. E. Minturn, T. Hishiki, H. Zhao, Q. Wang, A. Cnaan, J. Maris, A. E. Evans, and G. M. Brodeur (2005)
Cancer Res. 65, 9868-9875
   Abstract »    Full Text »    PDF »
Genetic Heterogeneity of the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer Cell Lines Revealed by a Rapid and Sensitive Detection System, the Peptide Nucleic Acid-Locked Nucleic Acid PCR Clamp.
Y. Nagai, H. Miyazawa, Huqun, T. Tanaka, K. Udagawa, M. Kato, S. Fukuyama, A. Yokote, K. Kobayashi, M. Kanazawa, et al. (2005)
Cancer Res. 65, 7276-7282
   Abstract »    Full Text »    PDF »
Homozygous Deletions and Chromosome Amplifications in Human Lung Carcinomas Revealed by Single Nucleotide Polymorphism Array Analysis.
X. Zhao, B. A. Weir, T. LaFramboise, M. Lin, R. Beroukhim, L. Garraway, J. Beheshti, J. C. Lee, K. Naoki, W. G. Richards, et al. (2005)
Cancer Res. 65, 5561-5570
   Abstract »    Full Text »    PDF »
Epidermal Growth Factor Receptor Mutations, Small-Molecule Kinase Inhibitors, and Non-Small-Cell Lung Cancer: Current Knowledge and Future Directions.
W. Pao and V. A. Miller (2005)
J. Clin. Oncol. 23, 2556-2568
   Abstract »    Full Text »    PDF »
Src Family Kinase Inhibitors Block Amphiregulin-Mediated Autocrine ErbB Signaling in Normal Human Keratinocytes.
S. Kansra, S. W. Stoll, J. L. Johnson, and J. T. Elder (2005)
Mol. Pharmacol. 67, 1145-1157
   Abstract »    Full Text »    PDF »
Multidrug Transporter ABCG2 Prevents Tumor Cell Death Induced by the Epidermal Growth Factor Receptor Inhibitor Iressa (ZD1839, Gefitinib).
N. B. Elkind, Z. Szentpetery, A. Apati, C. Ozvegy-Laczka, G. Varady, O. Ujhelly, K. Szabo, L. Homolya, A. Varadi, L. Buday, et al. (2005)
Cancer Res. 65, 1770-1777
   Abstract »    Full Text »    PDF »
The role of MAPK pathways in the action of chemotherapeutic drugs.
S. Boldt, U. H. Weidle, and W. Kolch (2002)
Carcinogenesis 23, 1831-1838
   Abstract »    Full Text »    PDF »
Overexpression of Epidermal Growth Factor and Hepatocyte Growth Factor Receptors in a Proportion of Gastrinomas Correlates with Aggressive Growth and Lower Curability.
P. L. Peghini, M. Iwamoto, M. Raffeld, Y.-J. Chen, S. U. Goebel, J. Serrano, and R. T. Jensen (2002)
Clin. Cancer Res. 8, 2273-2285
   Abstract »    Full Text »    PDF »
Retinoids Suppress Epidermal Growth Factor-associated Cell Proliferation by Inhibiting Epidermal Growth Factor Receptor-dependent ERK1/2 Activation.
J. F. Sah, R. L. Eckert, R. A. S. Chandraratna, and E. A. Rorke (2002)
J. Biol. Chem. 277, 9728-9735
   Abstract »    Full Text »    PDF »
Early Growth Response-1 Gene Mediates Up-Regulation of Epidermal Growth Factor Receptor Expression during Hypoxia.
H. Nishi, K. H. Nishi, and A. C. Johnson (2002)
Cancer Res. 62, 827-834
   Abstract »    Full Text »    PDF »
Identification of a Novel AU-Rich Element in the 3' Untranslated Region of Epidermal Growth Factor Receptor mRNA That Is the Target for Regulated RNA-Binding Proteins.
L. A. Balmer, D. J. Beveridge, J. A. Jazayeri, A. M. Thomson, C. E. Walker, and P. J. Leedman (2001)
Mol. Cell. Biol. 21, 2070-2084
   Abstract »    Full Text »
Radiotoxicity of h-R3 monoclonal antibody labeled with 188Re administered intracerebrally in rats.
B Gonzalez, A Casaco, P Alvarez, M Leon, M Arteaga, A Leon, E Santana, A Bada, R Figueredo, R Hernandez, et al. (2000)
Human and Experimental Toxicology 19, 684-692
   Abstract »    PDF »
Cross-talk between Epidermal Growth Factor Receptor and c-Met Signal Pathways in Transformed Cells.
M. Jo, D. B. Stolz, J. E. Esplen, K. Dorko, G. K. Michalopoulos, and S. C. Strom (2000)
J. Biol. Chem. 275, 8806-8811
   Abstract »    Full Text »    PDF »
Potato Carboxypeptidase Inhibitor, a T-knot Protein, Is an Epidermal Growth Factor Antagonist That Inhibits Tumor Cell Growth.
C. Blanco-Aparicio, M. A. Molina, E. Fernandez-Salas, M. L. Frazier, J. M. Mas, E. Querol, F. X. Aviles, and R. de Llorens (1998)
J. Biol. Chem. 273, 12370-12377
   Abstract »    Full Text »    PDF »
Activation of Epidermal Growth Factor Receptor Gene Transcription by Phorbol 12-Myristate 13-Acetate Is Mediated by Activator Protein 2.
A. C. Johnson and A. C. Johnson (1996)
J. Biol. Chem. 271, 3033-3038
   Abstract »    Full Text »    PDF »
EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling.
P. Di Fiore, O Segatto, W. Taylor, S. Aaronson, and J. Pierce (1990)
Science 248, 79-83
   Abstract »    PDF »
Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.
T. Velu, L Beguinot, W. Vass, M. Willingham, G. Merlino, I Pastan, and D. Lowy (1987)
Science 238, 1408-1410
   Abstract »    PDF »
erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells.
P. Di Fiore, J. Pierce, M. Kraus, O Segatto, C. King, and S. Aaronson (1987)
Science 237, 178-182
   Abstract »    PDF »
Gene amplification of c-myc and N-myc in small cell carcinoma of the lung.
A. Wong, J. Ruppert, J Eggleston, Hamilton SR, S. Baylin, and B Vogelstein (1986)
Science 233, 461-464
   Abstract »    PDF »
Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.
L Coussens, T. Yang-Feng, Y. Liao, E Chen, A Gray, J McGrath, P. Seeburg, T. Libermann, J Schlessinger, U Francke, et al. (1985)
Science 230, 1132-1139
   Abstract »    PDF »
The action of oncogenes in the cytoplasm and nucleus.
R. Weinberg (1985)
Science 230, 770-776
   Abstract »    PDF »
The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor.
A. Schechter, M. Hung, L Vaidyanathan, R. Weinberg, T. Yang-Feng, U Francke, A Ullrich, and L Coussens (1985)
Science 229, 976-978
   Abstract »    PDF »
Activated expression of the N-myc gene in human neuroblastomas and related tumors.
N. Kohl, C. Gee, and F. Alt (1984)
Science 226, 1335-1337
   Abstract »    PDF »



ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)